 Mark Krueger |
Mark Krueger, who ran his own healthcare constitutency relations consulting firm for 23 years before selling it in 2018, has joined APCO Worldwide as executive director in its New York office.
Working for biotech, pharmaceutical, medical device and diagnostics clients, Mark Krueger & Assocs. is noted for creating/implementing ways to speed drug discovery, quicken regulatiory approval and demonstrate its value to lead to appropriate pricing, access and reimbursement.
Brad Staples, APCO CEO, praised Krueger as a "trusted partner" to patient, consumer groups, NGOs and professional societies. "Mark has a proven track record of creating respectful partnerships focused on interests shared between these groups, industry, government and other members of the community,” he said.
Alexandra Lazorchak leads APCO's North American health practice and co-chairs the global health unit with James Tyrrell.
Binaytara, the Bellevue, WA-based nonprofit dedicated to improving access to cancer care and fostering scientific research, has appointed FINN Partners as its global PR firm.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
